Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 2
2014 3
2015 3
2016 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Penetration and haptenation of p-phenylenediamine.
Pot LM, Scheitza SM, Coenraads PJ, Blömeke B. Pot LM, et al. Contact Dermatitis. 2013 Apr;68(4):193-207. doi: 10.1111/cod.12032. Contact Dermatitis. 2013. PMID: 23510340 Free article. Review.
Two Venovenous Extracorporeal Membrane Oxygenation for One Gunshot.
Pot L, Porto A, Le Saux A, Bichon A, Cauchois E, Gainnier M, Carvelli J, Bourenne J. Pot L, et al. Case Rep Crit Care. 2022 Jul 20;2022:1070830. doi: 10.1155/2022/1070830. eCollection 2022. Case Rep Crit Care. 2022. PMID: 35909992 Free PMC article.
89Zr-bevacizumab PET imaging in primary breast cancer.
Gaykema SB, Brouwers AH, Lub-de Hooge MN, Pleijhuis RG, Timmer-Bosscha H, Pot L, van Dam GM, van der Meulen SB, de Jong JR, Bart J, de Vries J, Jansen L, de Vries EG, Schröder CP. Gaykema SB, et al. Among authors: pot l. J Nucl Med. 2013 Jul;54(7):1014-8. doi: 10.2967/jnumed.112.117218. Epub 2013 May 7. J Nucl Med. 2013. PMID: 23651946 Free article. Clinical Trial.
Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts.
ter Weele EJ, Terwisscha van Scheltinga AG, Kosterink JG, Pot L, Vedelaar SR, Lamberts LE, Williams SP, Lub-de Hooge MN, de Vries EG. ter Weele EJ, et al. Among authors: pot l. Oncotarget. 2015 Dec 8;6(39):42081-90. doi: 10.18632/oncotarget.5877. Oncotarget. 2015. PMID: 26536664 Free PMC article.
Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.
Terwisscha van Scheltinga AG, Berghuis P, Nienhuis HH, Timmer-Bosscha H, Pot L, Gaykema SB, Lub-de Hooge MN, Kosterink JG, de Vries EG, Schröder CP. Terwisscha van Scheltinga AG, et al. Among authors: pot l. Eur J Cancer. 2014 Sep;50(14):2508-16. doi: 10.1016/j.ejca.2014.06.008. Epub 2014 Jul 12. Eur J Cancer. 2014. PMID: 25027745
12 results